Centre Hospitalier Regional D'Angers

The Centre Hospitalier Regional D'Angers is active in cardiovascular diseases and related circulatory phenomena, with studies focused on conditions such as acute myocardial infarction, deep vein thrombosis, pulmonary embolism, venous thromboembolism, and pulmonary hypertension. This research is largely aimed at improving prevention, diagnosis, and treatment effectiveness in common and high-risk vascular disorders.

• Evaluating new approaches for pulmonary hypertension and pulmonary hypertension associated with COPD
• Studying better strategies to prevent and manage venous thromboembolism and related clotting events
• Assessing treatment effectiveness in serious cardiovascular disease and acute vascular complications

These trials reflect a strong clinical focus on reducing complications and improving outcomes for patients with major vascular and heart-related diseases.

Research at this site also covers respiratory tract diseases and critical care, including COPD, pneumonia, progressive pulmonary fibrosis, interstitial lung disease, and respiratory distress syndrome in preterm babies. The trials are designed to test new therapies, improve supportive care, and understand which treatments best preserve lung function and survival.

• Testing therapies for COPD and severe respiratory failure in intensive care settings
• Evaluating treatments for progressive pulmonary fibrosis and other chronic lung diseases
• Improving care for preterm infants with breathing complications

Several studies also examine ways to improve hospital recovery, ventilator-free days, and comfort in critically ill patients.

Much of the clinical research here centers on neoplasms and hematologic diseases, especially non-small cell lung cancer, hepatocellular carcinoma, bladder cancer, myelodysplastic syndromes, multiple myeloma, acute myeloid leukemia, and lymphoma. The purpose of these trials is to evaluate new cancer treatments, refine personalized therapy, and improve long-term disease control.

• Testing immunotherapy and targeted treatment strategies for non-small cell lung cancer
• Studying personalized and adjuvant approaches in liver cancer, bladder cancer, and colon cancer
• Evaluating new options for blood cancers such as MDS, AML, myeloma, and lymphoma

The oncology portfolio includes both treatment intensification and treatment de-escalation studies, with a clear interest in matching therapy to disease biology.

This site is also involved in research on immune system diseases and transplant-related care, including immune thrombocytopenia, ANCA-associated vasculitis, kidney transplant, and haploidentical hematopoietic stem cell transplantation. The trials aim to improve immune control, reduce relapse, and make transplant outcomes safer and more durable.

• Assessing therapies for immune thrombocytopenia and vasculitis
• Studying infection prevention and immune protection after kidney transplant
• Improving outcomes after hematopoietic stem cell transplantation for blood cancers

These studies show a strong interest in balancing immune suppression with protection against relapse and infection.

Clinical trials at Centre Hospitalier Regional D'Angers also address diagnosis, therapeutics, and surgical procedures, with a focus on digestive cancer surgery, labor induction, rapid sequence induction, and postoperative recovery. These studies are intended to improve safety, guide treatment decisions, and optimize outcomes around surgery and hospital care.

• Testing ways to improve recovery after digestive cancer surgery
• Comparing strategies for labor induction and obstetric management
• Evaluating better approaches to anesthesia and postoperative comfort in critical care

Overall, the site combines procedural research with broader diagnostic and therapeutic studies to support better care across complex hospital settings.